Literature DB >> 12059037

Reduction of trophic support enhances apoptosis in PC12 cells expressing Alzheimer's APP mutation and sensitizes cells to staurosporine-induced cell death.

Steffen Leutz1, Barbara Steiner, Celio A Marques, Christian Haass, Walter E Müller, Anne Eckert.   

Abstract

Mutations in the amyloid precursor protein (APP) gene are known as causative factors in the pathogenesis of early-onset familial Alzheimer's disease (FAD). In this study, the influence of the Swedish double-mutation form of APP (APPsw; KM670/671NL) on apoptosis regulation in PC12 cells was investigated. APPsw-transfected PC12 cells were compared with wild-type APP (APPwt)-expressing and vector-transfected PC12 cells with regard to their susceptibility to cell death induced by the reduction of trophic support or by additional treatment with staurosporine. Expression of APPsw markedly enhanced the level of apoptotic PC12 cells induced by serum reduction. A similar hypersensitivity of APPsw-expressing PC12 cells could be detected after differentiation with nerve growth factor under serum-reduced conditions. Likewise, the expression of APPsw rendered PC12 cells more vulnerable to staurosporine but only under serum-reduced conditions. This APPsw-effect disappeared in high serum-containing medium. Thus, expression of APPsw seems to enhance cellular sensitivity not in general but after the reduction of trophic factors probably by causing oxidative stress. This, in turn, may sensitize cells to secondary apoptotic stimuli. Moreover, the mutation-specific increase in vulnerability to cell death was only seen at the stage of apoptotic nuclei, but not using methods measuring cell death by determining metabolic activity or membrane integrity. Therefore, the expression of APPsw seems to affect specifically apoptotic cell death rather than overall cell death in vitro. Our study further emphasizes the pathogenic role of mutant APP and may provide new insights in the mechanisms underlying the massive neurodegeneration in brain from patients bearing the APPsw mutation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12059037     DOI: 10.1385/JMN:18:3:189

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  48 in total

1.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.

Authors:  M B Hansen; S E Nielsen; K Berg
Journal:  J Immunol Methods       Date:  1989-05-12       Impact factor: 2.303

2.  Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1.

Authors:  K Duff; C Eckman; C Zehr; X Yu; C M Prada; J Perez-tur; M Hutton; L Buee; Y Harigaya; D Yager; D Morgan; M N Gordon; L Holcomb; L Refolo; B Zenk; J Hardy; S Younkin
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

3.  Survival factor-insensitive generation of reactive oxygen species induced by serum deprivation in neuronal cells.

Authors:  T Satoh; N Sakai; Y Enokido; Y Uchiyama; H Hatanaka
Journal:  Brain Res       Date:  1996-09-09       Impact factor: 3.252

4.  Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death.

Authors:  M S Shearman; C I Ragan; L L Iversen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

5.  Widespread peroxynitrite-mediated damage in Alzheimer's disease.

Authors:  M A Smith; P L Richey Harris; L M Sayre; J S Beckman; G Perry
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

6.  Elevated vulnerability to oxidative stress-induced cell death and activation of caspase-3 by the Swedish amyloid precursor protein mutation.

Authors:  A Eckert; B Steiner; C Marques; S Leutz; H Romig; C Haass; W E Müller
Journal:  J Neurosci Res       Date:  2001-04-15       Impact factor: 4.164

7.  Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation.

Authors:  B Wolozin; K Iwasaki; P Vito; J K Ganjei; E Lacanà; T Sunderland; B Zhao; J W Kusiak; W Wasco; L D'Adamio
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

8.  An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

Authors:  N Suzuki; T T Cheung; X D Cai; A Odaka; L Otvos; C Eckman; T E Golde; S G Younkin
Journal:  Science       Date:  1994-05-27       Impact factor: 47.728

9.  Manganese-induced reactive oxygen species: comparison between Mn+2 and Mn+3.

Authors:  S F Ali; H M Duhart; G D Newport; G W Lipe; W Slikker
Journal:  Neurodegeneration       Date:  1995-09

Review 10.  The significance of the Swedish APP670/671 mutation for the development of Alzheimer's disease amyloidosis.

Authors:  J Johnston; C O'Neill; L Lannfelt; B Winblad; R F Cowburn
Journal:  Neurochem Int       Date:  1994-07       Impact factor: 3.921

View more
  8 in total

1.  The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by beta-amyloid peptide.

Authors:  C Kurz; I Ungerer; U Lipka; S Kirr; T Schütt; A Eckert; K Leuner; W E Müller
Journal:  Br J Pharmacol       Date:  2010-03-09       Impact factor: 8.739

2.  Piracetam improves mitochondrial dysfunction following oxidative stress.

Authors:  Uta Keil; Isabel Scherping; Susanne Hauptmann; Katin Schuessel; Anne Eckert; Walter E Müller
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

3.  Development of an ischemic tolerance model in a PC12 cell line.

Authors:  Joëlle A Hillion; Kenzo Takahashi; Dragan Maric; Christl Ruetzler; Jeffery L Barker; John M Hallenbeck
Journal:  J Cereb Blood Flow Metab       Date:  2005-02       Impact factor: 6.200

4.  The interaction of beta-amyloid protein with cellular membranes stimulates its own production.

Authors:  Imke Peters; Urule Igbavboa; Tanja Schütt; Schamim Haidari; Ulrike Hartig; Ximena Rosello; Steffi Böttner; Ekaterini Copanaki; Thomas Deller; Donat Kögel; W Gibson Wood; Walter E Müller; Gunter P Eckert
Journal:  Biochim Biophys Acta       Date:  2009-02-02

5.  Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicity.

Authors:  Anne Eckert; Karen Schmitt; Jürgen Götz
Journal:  Alzheimers Res Ther       Date:  2011-05-05       Impact factor: 6.982

6.  Battery of behavioral tests in mice to study postoperative delirium.

Authors:  Mian Peng; Ce Zhang; Yuanlin Dong; Yiying Zhang; Harumasa Nakazawa; Masao Kaneki; Hui Zheng; Yuan Shen; Edward R Marcantonio; Zhongcong Xie
Journal:  Sci Rep       Date:  2016-07-20       Impact factor: 4.379

7.  Effects and mechanism of dexmedetomidine on neuronal cell injury induced by hypoxia-ischemia.

Authors:  Ya-Jun Liu; Duan-Yu Wang; Yong-Jian Yang; Wei-Fu Lei
Journal:  BMC Anesthesiol       Date:  2017-08-30       Impact factor: 2.217

8.  Sex-associated differences in mitochondrial function in human peripheral blood mononuclear cells (PBMCs) and brain.

Authors:  C Silaidos; U Pilatus; R Grewal; S Matura; B Lienerth; J Pantel; G P Eckert
Journal:  Biol Sex Differ       Date:  2018-07-25       Impact factor: 5.027

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.